Importer of Controlled Substances; Notice of Registration; Noramco, Inc., 35052-35053 [2013-13869]

Download as PDF 35052 Federal Register / Vol. 78, No. 112 / Tuesday, June 11, 2013 / Notices Carsem filed a combined petition for panel rehearing and for rehearing en banc. The Court denied Carsem’s petition on December 7, 2012, and issued its mandate on December 19, 2012, returning jurisdiction to the Commission. On January 14, 2013, the Commission issued an Order (‘‘Commission’s Order’’) requesting the parties to the investigation to submit initial comments regarding what further proceedings must be conducted to comply with the Federal Circuit’s August 22, 2012, judgment in Amkor Technology. The parties filed their initial and responsive submissions. Having examined the record in this investigation, including the parties’ submissions filed in response to the Commission’s Order, the Commission has determined to request briefing from the parties on only the following issues, with reference to the applicable law and the evidentiary record: wreier-aviles on DSK5TPTVN1PROD with NOTICES Whether there is any intervening legal precedent since the issuance of the 2004 Final ID that precludes or warrants the ALJ’s determination that Amkor satisfied the economic prong of the domestic industry requirement under section 337(a)(3)(A), and did not satisfy the economic prong under section 337(a)(3)(B). See 19 U.S.C. 1337(a)(3)(A) and (B). In connection with the final disposition of this investigation, the Commission may (1) issue an order that could result in the exclusion of the subject articles from entry into the United States, and/or (2) issue one or more cease and desist orders that could result in the respondents being required to cease and desist from engaging in unfair acts in the importation and sale of such articles. Accordingly, the Commission is interested in receiving written submissions that address the form of remedy, if any, that should be ordered. If a party seeks exclusion of an article from entry into the United States for purposes other than entry for consumption, the party should so indicate and provide information establishing that activities involving other types of entry either are adversely affecting it or are likely to do so. For background, see Certain Devices for Connecting Computers via Telephone Lines, Inv. No. 337–TA–360, USITC Pub. No. 2843 Comm’n Op. (Dec. 1994). If the Commission contemplates some form of remedy, it must consider the effects of that remedy upon the public interest. The factors the Commission will consider include the effect that an exclusion order and/or cease and desist orders would have on (1) the public health and welfare, (2) competitive conditions in the U.S. economy, (3) U.S. VerDate Mar<15>2010 15:13 Jun 10, 2013 Jkt 229001 production of articles that are like or directly competitive with those that are subject to investigation, and (4) U.S. consumers. The Commission is therefore interested in receiving written submissions that address the aforementioned public interest factors in the context of this investigation. The Commission also requests briefing as to the following question: Whether for purposes of our public interest analysis, there are products comparable to the subject articles that are noninfringing products in the U.S. market. If the Commission orders some form of remedy, the President has 60 days to approve or disapprove the Commission’s action. During this period, the subject articles would be entitled to enter the United States under bond, in an amount determined by the Commission and prescribed by the Secretary of the Treasury. The Commission is therefore interested in receiving submissions concerning the amount of the bond that should be imposed. Written Submissions: The parties to the investigation are requested to file written submissions on the issues specified in this Notice. The submissions should be concise and thoroughly referenced to the record in this investigation. Parties to the investigation, interested government agencies, and any other interested persons are encouraged to file written submissions on the issues of remedy, the public interest, and bonding. Such submissions should address the recommended determination by the ALJ on remedy and bonding issued on November 18, 2004. Complainant and the Commission investigative attorney are also requested to submit proposed remedial orders for the Commission’s consideration. Complainant is further requested to provide the expiration dates of the asserted patents at issue in this investigation and state the HTSUS number under which the accused articles are imported. The written submissions and proposed remedial orders must be filed no later than the close of business on Wednesday, June 19, 2013. Reply submissions must be filed no later than the close of business on Wednesday, June 26, 2013. No further submissions on these issues will be permitted unless otherwise ordered by the Commission. Persons filing written submissions must file the original document electronically on or before the deadlines stated above and submit 8 true paper copies to the Office of the Secretary by noon the next day pursuant to section 210.4(f) of the Commission’s Rules of PO 00000 Frm 00079 Fmt 4703 Sfmt 4703 Practice and Procedure (19 CFR 210.4(f)). Submissions should refer to the investigation number (‘‘Inv. No. 337–TA–501’’) in a prominent place on the cover page and/or the first page. (See Handbook for Electronic Filing Procedures, http://www.usitc.gov/ secretary/fed_reg_notices/rules/ handbook_on_electronic_filing.pdf). Persons with questions regarding filing should contact the Secretary (202–205– 2000). Any person desiring to submit a document to the Commission in confidence must request confidential treatment. All such requests should be directed to the Secretary to the Commission and must include a full statement of the reasons why the Commission should grant such treatment. See 19 CFR 201.6. Documents for which confidential treatment by the Commission is properly sought will be treated accordingly. A redacted nonconfidential version of the document must also be filed simultaneously with the any confidential filing. All nonconfidential written submissions will be available for public inspection at the Office of the Secretary and on EDIS. The authority for the Commission’s determination is contained in section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and in sections 210.42–.46 of the Commission’s Rules of Practice and Procedure (19 CFR 210.42–.46). Issued: June 5, 2013. By order of the Commission. Lisa R. Barton, Acting Secretary to the Commission. [FR Doc. 2013–13747 Filed 6–10–13; 8:45 am] BILLING CODE 7020–02–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Registration; Noramco, Inc. By Notice dated March 12, 2013, and published in the Federal Register on March 20, 2013, 78 FR 17230, Noramco, Inc., 1440 Olympic Drive, Athens, Georgia 30601, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the basic classes of controlled substances: Drug Phenylacetone (8501) .................. Thebaine (9333) ........................... Poppy Straw Concentrate (9670) Tapentadol (9780) ........................ E:\FR\FM\11JNN1.SGM 11JNN1 Schedule II II II II Federal Register / Vol. 78, No. 112 / Tuesday, June 11, 2013 / Notices The company plans to import Thebaine (9333) analytical reference standards for distribution to its customers. The company plans to import an intermediate form of Tapentadol (9780) to bulk manufacture Tapentadol for distribution to its customers. The company plans to import Phenylacetone (8501) and Poppy Straw Concentrate (9670) to manufacture other controlled substances. The company has withdrawn its request to import the drug code Noroxymorphone (9668). Comments and requests for hearings on applications to import narcotic raw material are not appropriate. 72 FR 3417 (2007). DEA has considered the factors in 21 U.S.C. 823(a) and 952(a), and determined that the registration of Noramco, Inc., to import the basic classes of controlled substances is consistent with the public interest, and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971, at this time. DEA has investigated Noramco, Inc., to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR § 1301.34, the above named company is granted registration as an importer of the basic classes of controlled substances listed. Dated: May 24, 2013. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. BILLING CODE 4410–09–P DEPARTMENT OF LABOR wreier-aviles on DSK5TPTVN1PROD with NOTICES Office of the Secretary Agency Information Collection Activities; Submission for OMB Review; Comment Request; Evaluation of the Army Unemployment Compensation for Ex-Servicemembers (UCX) Claimants Initiative Notice. SUMMARY: The Department of Labor (DOL), as part of its continuing effort to reduce paperwork and respondent VerDate Mar<15>2010 15:13 Jun 10, 2013 Jkt 229001 Written comments must be submitted to the office listed in the addressee section below on or before August 12, 2013. ADDRESSES: You may submit comments by either one of the following methods: Email: javar.janet.o@dol.gov; Mail or Courier: Janet Javar, Chief Evaluation Office, U.S. Department of Labor, Room S–2218, 200 Constitution Avenue NW., Washington, DC 20210. Instructions: Please submit one copy of your comments by only one method. All submissions received must include the agency name and OMB Control Number identified above for this information collection. Because we continue to experience delays in receiving mail in the Washington, DC area, commenters are strongly encouraged to transmit their comments electronically via email or to submit them by mail early. Comments, including any personal information provided, become a matter of public record. They will also be summarized and/or included in the request for OMB approval of the information collection request. DATES: FOR FURTHER INFORMATION CONTACT: [FR Doc. 2013–13869 Filed 6–10–13; 8:45 am] ACTION: burden, conducts a preclearance consultation program to provide the general public and Federal agencies with an opportunity to comment on proposed and/or continuing collections of information in accordance with the Paperwork Reduction Act of 1995 (PRA95). This program helps to ensure that required data can be provided in the desired format, reporting burden (time and financial resources) is minimized, collection instruments are clearly understood, and the impact of collection requirements on respondents can be properly assessed. A copy of the proposed ICR can be obtained by contacting the office listed below in the addressee section of this notice. Janet Javar by telephone at 202–693– 5954 (this is not a toll-free number) or by email at javar.janet.o@dol.gov. SUPPLEMENTARY INFORMATION: I. Background: The Army Unemployment Compensation for ExService Members (UCX) Claimants’ Initiative, funded by the U.S. Department of Labor, Employment and Training Administration (ETA), provides grants to four states to improve strategies for providing reemployment services to Army UCX claimants and for leveraging assets and sharing data across partners. The major goals of the initiative are to create a strong collaborative partnership among the Unemployment Insurance (UI) system, the public workforce system, and the PO 00000 Frm 00080 Fmt 4703 Sfmt 4703 35053 three components of the Army (active, National Guard, and Reserve) that will support the rapid reemployment of UCX claimants; improve the sharing of UCX data that will lead to improved outreach and better understanding of UCX claimants and their service delivery needs; and increase outreach, exposure to jobs, and reemployment strategies for UCX claimants that fully leverage existing resources with new and innovative service delivery strategies. The period of performance for the grants is from July 1, 2012, to June 30, 2014. The purpose of the evaluation, funded by the Chief Evaluation Office, is to determine the extent to which the initiative’s goals were achieved by each of the four grantee states. The evaluation will examine the services received by UCX claimants and how claimants’ employment outcomes changed over the course of the grant period. Policymakers, program administrators, and service providers will gain information about the relative effectiveness of various strategies developed by states, ease of implementation, and suggestions for replication. This package requests clearance for semi-structured discussions that will take place during a single round of twoday visits to each of the sites in the winter of 2013–2014. The site visits will involve an array of individuals that varies by state based on the projects that each state has decided to implement. Conversations will take place with grantee leaders, staff of an American Job Center, and representatives of the UI system in each state. Other discussants will include a suitable combination of representatives of the Army and other participants in the initiative. The site visit will facilitate an assessment of the progress of these efforts, information gathering, and potential for the delivery of additional in-person technical assistance. II. Desired Focus of Comments: Currently, the Department of Labor is soliciting comments concerning the above data collection for Evaluation of the Army UCX Claimants Initiative. Comments are requested to: * Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; * Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; E:\FR\FM\11JNN1.SGM 11JNN1

Agencies

[Federal Register Volume 78, Number 112 (Tuesday, June 11, 2013)]
[Notices]
[Pages 35052-35053]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-13869]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration; 
Noramco, Inc.

    By Notice dated March 12, 2013, and published in the Federal 
Register on March 20, 2013, 78 FR 17230, Noramco, Inc., 1440 Olympic 
Drive, Athens, Georgia 30601, made application by renewal to the Drug 
Enforcement Administration (DEA) to be registered as an importer of the 
basic classes of controlled substances:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Phenylacetone (8501).......................  II
Thebaine (9333)............................  II
Poppy Straw Concentrate (9670).............  II
Tapentadol (9780)..........................  II
------------------------------------------------------------------------


[[Page 35053]]

    The company plans to import Thebaine (9333) analytical reference 
standards for distribution to its customers. The company plans to 
import an intermediate form of Tapentadol (9780) to bulk manufacture 
Tapentadol for distribution to its customers. The company plans to 
import Phenylacetone (8501) and Poppy Straw Concentrate (9670) to 
manufacture other controlled substances.
    The company has withdrawn its request to import the drug code 
Noroxymorphone (9668).
    Comments and requests for hearings on applications to import 
narcotic raw material are not appropriate. 72 FR 3417 (2007).
    DEA has considered the factors in 21 U.S.C. 823(a) and 952(a), and 
determined that the registration of Noramco, Inc., to import the basic 
classes of controlled substances is consistent with the public 
interest, and with United States obligations under international 
treaties, conventions, or protocols in effect on May 1, 1971, at this 
time. DEA has investigated Noramco, Inc., to ensure that the company's 
registration is consistent with the public interest. The investigation 
has included inspection and testing of the company's physical security 
systems, verification of the company's compliance with state and local 
laws, and a review of the company's background and history. Therefore, 
pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 
Sec.  1301.34, the above named company is granted registration as an 
importer of the basic classes of controlled substances listed.

    Dated: May 24, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2013-13869 Filed 6-10-13; 8:45 am]
BILLING CODE 4410-09-P